- Home
- VRNA vs RMBS Comparison
VRNA vs RMBS Comparison
Compare VRNA & RMBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- RMBS
- Stock Information
- Founded
- VRNA 2005
- RMBS 1990
- Country
- VRNA United Kingdom
- RMBS United States
- Employees
- VRNA N/A
- RMBS N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- RMBS Semiconductors
- Sector
- VRNA Health Care
- RMBS Technology
- Exchange
- VRNA Nasdaq
- RMBS Nasdaq
- Market Cap
- VRNA 8.3B
- RMBS 8.0B
- IPO Year
- VRNA 2017
- RMBS 1997
- Fundamental
- Price
- VRNA $106.91
- RMBS $97.01
- Analyst Decision
- VRNA Buy
- RMBS Strong Buy
- Analyst Count
- VRNA 11
- RMBS 6
- Target Price
- VRNA $114.10
- RMBS $97.83
- AVG Volume (30 Days)
- VRNA 1.5M
- RMBS 2.9M
- Earning Date
- VRNA 11-03-2025
- RMBS 10-27-2025
- Dividend Yield
- VRNA N/A
- RMBS N/A
- EPS Growth
- VRNA N/A
- RMBS 0.94
- EPS
- VRNA N/A
- RMBS 2.11
- Revenue
- VRNA $221,673,000.00
- RMBS $645,488,000.00
- Revenue This Year
- VRNA $909.96
- RMBS $27.27
- Revenue Next Year
- VRNA $76.47
- RMBS $13.32
- P/E Ratio
- VRNA N/A
- RMBS $45.85
- Revenue Growth
- VRNA N/A
- RMBS 35.17
- 52 Week Low
- VRNA $31.09
- RMBS $40.12
- 52 Week High
- VRNA $106.94
- RMBS $109.15
- Technical
- Relative Strength Index (RSI)
- VRNA 72.60
- RMBS 58.48
- Support Level
- VRNA $105.78
- RMBS $95.04
- Resistance Level
- VRNA $106.86
- RMBS $104.12
- Average True Range (ATR)
- VRNA 0.16
- RMBS 5.87
- MACD
- VRNA -0.04
- RMBS 0.04
- Stochastic Oscillator
- VRNA 98.26
- RMBS 64.67
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About RMBS Rambus Inc.
Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.